Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Express Scripts Offers Access To Lives, Not Cash, For 20% Of PlanetRx.com

Executive Summary

Express Scripts is acquiring 19.9% of the online pharmacy PlanetRx.com in exchange for access to the PBM's customer base and third-party contracts. Express Scripts is not using cash or stock to pay for its investment in PlanetRx.

You may also be interested in...



MIMRx.com Will See $100 Mil. Revenues In First Year, CEO Predicts

Online pharmacy MIMRx.com will collect over $100 mil. in revenues in its first year, MIM Corporation Chairman & CEO Richard Friedman said Feb. 15 at the Warburg Dillon Read Healthcare Services Conference held in New York City.

MIMRx.com Will See $100 Mil. Revenues In First Year, CEO Predicts

Online pharmacy MIMRx.com will collect over $100 mil. in revenues in its first year, MIM Corporation Chairman & CEO Richard Friedman said Feb. 15 at the Warburg Dillon Read Healthcare Services Conference held in New York City.

PlanetRx Plans To Fill All Express Scripts Internet Rxs In Its Own Facility

PlanetRx.com's revenues from its Express Scripts partnership will rise as the online pharmacy takes over the filling of Internet prescriptions from the pharmacy benefits manager, the company indicated during a Jan. 25 conference call.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034779

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel